Get access to our best features
Get access to our best features
Published

FDA calls out AbbVie over ‘misleading’ commercial featuring Serena Williams

Summary by Chicago Tribune
The U.S. Food and Drug Administration is taking North Chicago-based drugmaker AbbVie to task, warning in a recent letter that a migraine medication commercial featuring Serena Williams is “misleading.” The television commercial shows Williams in a talk show dressing room, appearing to experience migraine pain, closing her eyes and holding a hand up to her head. She then starts walking and a logo for the AbbVie medication Ubrelvy appears in a bac…
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 100% of the sources are Center
100% Center
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Sources are mostly out of (0)